Upstart: Undervalued Relative To Its Growth Story

Upstart (UPST) is down over 60% year-over-year, but the author argues the decline is overdone and initiates a Buy view. Despite trading at ~13x forward P/E (a ~10% premium to the sector median), UPST is expected to grow revenue ~44% and deliver strong top- and bottom-line momentum. The piece also notes elevated bearish positioning with 27% short interest, framing the valuation as undervalued relative to growth.

Analysis

The setup is more about positioning than fundamentals: when a stock with this much short interest starts to re-rate, the first leg is usually mechanical cover plus factor chasing, not a clean revision to terminal value. That makes UPST tradable on any incremental evidence of stable credit performance, but it also means the upside can outrun the underlying business for a few weeks and then fade if the next print does not confirm acceleration.

The market is likely underpricing how fragile the narrative is to credit-cycle normalization. If revenue growth is being driven by easier comparisons or a benign credit backdrop, then a premium multiple can compress quickly once delinquency or funding costs move the wrong way; in that case, the stock behaves more like a high-beta consumer-credit proxy than a durable software compounder. Second-order beneficiaries of any squeeze are adjacent fintechs such as AFRM, SOFI, LC, and especially PGY, which can all catch sympathy flows even if their fundamentals diverge.

Contrarian view: consensus may be overweighting headline growth and underweighting the quality of growth. The real test over the next 1-3 months is not whether UPST can print high top-line growth, but whether it can do so without sacrificing underwriting discipline or partner economics. If the next earnings cycle shows any deterioration in credit metrics, the multiple can give back most of the recent re-rating quickly; if not, the move can extend for 6-18 months as shorts unwind and the market stops treating it as a broken story.

Key Decisions for Investors

• Tactical long UPST only as a small sizing trade into the next earnings window; treat it as a squeeze/confirmation trade, not a core fundamental hold. Invalidate if revenue growth decelerates or credit metrics worsen.
• Prefer an options-defined expression: buy UPST call spreads on weakness rather than stock, to capture a short-covering pop while capping downside if the growth story stalls.
• Relative-value idea: long UPST / short PGY basket on a 1-3 month horizon if you want to isolate the higher-quality re-rating candidate in credit-tech; cover the short if PGY shows stronger sequential growth or margin expansion.
• Watch-list alert, not a trade, on SOFI/AFRM/LC sympathy flows: if UPST rallies on multiple expansion alone, the group may follow mechanically; if the next print disappoints, the entire basket is vulnerable to de-rating.